Prof. Jim R Bonham,

is currently the National Laboratory Lead for the Newborn Screening Blood Spot Programme in the UK on behalf of Public Health England. He is also President of the International Society for Neonatal Screening with more than 500 members in 40 countries.

In 2012 he led a study to introduce additional inherited metabolic disorders into the national newborn screening programme in the UK. Four of these were incorporated as part of the programme in England and Wales from 2015.

He has interests in the organisation, quality and effectiveness of newborn screening and how this might be optimised and extended to benefit patients and families in the UK and Europe and more recently as part of the Global Taskforce on newborn screening, to low and middle income countries.

Prof Bonham has played an active role in several national and international professional organisations including the SSIEM, Royal College of Pathologists, UKNSLN, MetBioNet, NEQAS and UKAS. He helped found the British inherited Metabolic Disease Group and the International EQA provider for Inherited Metabolic Disorders – ERNDIM.

His efforts in these areas were generously recognised by the award of an MBE in 2020.